XML 30 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Profit for the year $ 130,717 $ 1,070 $ 342
Adjustments for:      
Income tax expense 43,837 12,325 20,820
Depreciation 167,297 140,579 173,208
Amortization 1,631 1,293 1,231
Depreciation of right of use assets 49,199 40,820 45,168
Loss/ (gain) from the disposal of other property items 397 (2,198) 329
Gain from the sale of farmland and other assets 0 (2,064) (1,354)
Loss / (Gain) from the sale of subsidiary (10) 554 0
Gain on acquisition of subsidiaries 0 0 (149)
Net loss/(gain)from the fair value adjustment of Investment properties 4,331 (1,077) 325
Equity settled share-based compensation granted 6,406 4,316 4,734
Loss / (gain) from derivative financial instruments and forwards 17,276 10,058 (469)
Interest, finance cost related to lease liabilities and other financial expense, net 75,610 47,686 62,653
Initial recognition and changes in fair value of non harvested biological assets (unrealized) (11,310) (32,975) (1,720)
Changes in net realizable value of agricultural produce after harvest (unrealized) 4,001 481 481
Provision and allowances 1,146 1,940 2,778
Net gain of inflation effects on the monetary items (11,541) (12,064) (92,437)
Foreign exchange (gains)/ losses, net (18,939) 109,266 108,458
Cash flow hedge – transfer from equity 52,650 24,363 15,594
Subtotal 512,698 344,373 339,992
Changes in operating assets and liabilities:      
Increase in trade and other receivables (40,449) (55,233) (17,664)
(Increase) / Decrease in inventories (102,815) (30,165) 9,998
Decrease / (Increase) in biological assets 7,597 (10,290) (27,037)
Increase in other assets (303) (35) (210)
(Increase) / Decrease in derivative financial instruments (29,319) 5,234 3,997
(Decrease) / Increase in trade and other payables (1,499) 828 13,102
Increase in payroll and social security liabilities 4,874 4,120 2,565
Increase / (Decrease) in provisions for other liabilities 74 380 (351)
Net cash generated from operating activities before taxes paid 350,858 259,212 324,392
Income tax paid (2,196) (2,087) (2,282)
Net cash generated from operating activities [1] 348,662 257,125 322,110
Cash flows from investing activities:      
Acquisition of business, net of cash and cash equivalents acquired 0 0 683
Purchases of property, plant and equipment (199,295) (168,529) (252,450)
Purchase of cattle and non current biological assets (11,776) (7,339) (4,950)
Purchases of intangible assets (1,934) (1,122) (8,617)
Interest received and others 16,729 25,421 7,210
Proceeds from disposal of other property items 2,946 3,482 2,652
Proceeds from the sale of farmland and other assets 8,099 16,022 5,833
Proceeds from the sale of subsidiary 10,010 10,149 0
Net cash used in investing activities [2] (175,221) (121,916) (249,639)
Cash flows from financing activities:      
Proceeds from long-term borrowings 30,972 116,015 108,271
Payments of long-term borrowings (108,425) (34,750) (101,826)
Proceeds from short-term borrowings 286,115 207,217 193,977
Payments of short-term borrowings (328,463) (233,540) (131,521)
Interest paid [3] (53,587) (60,026) (53,996)
Borrowings prepayment related expenses (3,068) 0 0
Collections / (Payments) of derivatives financial instruments 2,370 (1,687) 1,481
Lease payments (62,273) (40,336) (49,081)
Purchase of own shares (66,463) (4,365) (4,263)
Dividends paid to non-controlling interest (311) (2,447) (905)
Net cash used from financing activities [4] (303,133) (53,919) (37,863)
Net (decrease)/ increase in cash and cash equivalents (129,692) 81,290 34,608
Cash and cash equivalents at beginning of year 336,282 290,276 273,635
Effect of exchange rate changes and inflation on cash and cash equivalents [5] (6,824) (35,284) (17,967)
Cash and cash equivalents at end of year $ 199,766 $ 336,282 $ 290,276
[1] Includes (30,666), (14,956) and 23,550 of the combined effect of IAS 29 and IAS 21 of the Argentine subsidiaries for 2021, 2020 and 2019 , respectively.
[2] Includes (4,694), (429) and 3,851 of the combined effect of IAS 29 and IAS 21 of the Argentine subsidiaries for 2021, 2020 and 2019 , respectively.
[3] Includes (1,109), (1,638) and (14,340) of the combined effect of IAS 29 and IAS 21 of the Argentine subsidiaries for 2021, 2020 and 2019 , respectively.
[4] Includes 41,237, 15,694 and (13,061) of the combined effect of IAS 29 and IAS 21 of the Argentine subsidiaries for 2021, 2020 and 2019 , respectively.
[5] Includes (5,877), (309) and nil of the combined effect of IAS 29 and IAS 21 of the Argentine subsidiaries for 2021, 2020 and 2019 , respectively.